BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 8, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 27, 2001
View Archived Issues
Pharmacological interaction of irofulven and docetaxel under study
Read More
Additional MS-325 phase II clinical trial results presented this week
Read More
IND opened for the TranStem stem cell expansion system
Read More
Bayer worldwide licensing offer
Read More
Second orphan drug designation received for orBec in GVHD
Read More
First trial of thioredoxin inhibitor initiated in cancer patients
Read More
Potent new p38 MAP kinase inhibitor suppresses cytokine release, skin inflammation
Read More
Preclinical profile of ML-3000, a new COX/5-LO inhibitor, discussed at Inflammation 2001
Read More
UR-8880 exerts potent antiinflammatory effects in the absence of GI toxicity
Read More
ABT-627 beneficial in newborn lambs with congenital diaphragmatic hernia and pulmonary hypertension
Read More
Surfaxin not associated with changes in fetal human pulmonary cell physiology
Read More
Potential therapy for GVHD continues in late-stage clinical development
Read More
Irbesartan gives renal protection in type 2 diabetes patients independent of blood pressure effect
Read More
Alzheimer's Disease Cooperative Study receives research award from NIA
Read More
First IND filed for product emerging from Lilly/Ligand metabolic disease collaboration
Read More
Enrollment completed for phase IIa trial of repifermin for mucositis
Read More
Development candidate selected by GSK from Cytokinetics' second-generation antimitotics
Read More
Phase II trial assessing Angiozyme in combination with chemotherapy initiated
Read More
InterMune acquires worldwide rights to oritavancin from Lilly
Read More
Inflazyme initiates two trials to study novel antiinflammatory compounds
Read More
Genaera receives Cystic Fibrosis Foundation grant to develop Lomucin
Read More
Lundbeck presents several classes of 5-HT1A receptor ligands
Read More
HIV reverse transcriptase inhibitors described by Pfizer team
Read More
Recent U.S. patent covers new sulfonamides and use for atherosclerosis, restenosis
Read More
Phosphonic acid-based inhibitors of FBPase synthesized at Metabasis
Read More
Inhibitors of cytokine production under development by Hokuriku Seiyaku
Read More